Page last updated: 2024-08-24

duloxetine hydrochloride and Chemical and Drug Induced Liver Injury

duloxetine hydrochloride has been researched along with Chemical and Drug Induced Liver Injury in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (38.46)29.6817
2010's7 (53.85)24.3611
2020's1 (7.69)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, YA; Dong, J; Li, R; Li, T; Li, Z; Liu, J; Wang, Q; Wang, Y; Xue, R; Zhang, T; Zhang, Y; Zhuang, X1
Jiao, X; Li, Y; Liang, M; Tang, B; Wang, X; Xiao, Y; Xie, X1
Cunningham, EA; Kassam, AS; Musco, SE1
Chang, CL; Dore, DD; Li, H; Lin, ND; Norman, H; Perahia, DG; Regev, A1
Acharya, N; Heinloth, AN; Kuritzky, L; Regev, A; Robinson, M; Strombom, I; Wernicke, JF; Wohlreich, MM1
Acharya, N; D'Souza, DN; DiPietro, N; Gahimer, JL; Strombom, I; Uetrecht, JP; Wernicke, J1
Acharya, N; D'Souza, DN; Seeger, J; Strombom, I; Wernicke, JF1
D'Souza, DN; Henck, JW; Knadler, MP; Murray, I; Pangallo, B; Uetrecht, JP; Wang, F; Wernicke, J1
Fernandez-Fernandez, FJ; Fuente-Aguado, Jde L; Montero-Tinnirello, J; Rodriguez-Pecci, MS1
Bonkovsky, H; Chalasani, N; Fontana, RJ; Hayashi, PH; Hoofnagle, JH; Kleiner, D; Saxena, R; Vuppalanchi, R1
Seeger, JD; Strombom, I; Turnbull, B; Xue, F; Zhu, S1
Ammar, H; Malani, AK1

Reviews

3 review(s) available for duloxetine hydrochloride and Chemical and Drug Induced Liver Injury

ArticleYear
Answers to the most common questions about the hepatic safety profile of duloxetine.
    Postgraduate medicine, 2008, Volume: 120, Issue:2

    Topics: Antidepressive Agents; Chemical and Drug Induced Liver Injury; Depressive Disorder; Drug Approval; Drug Labeling; Duloxetine Hydrochloride; Humans; Liver Diseases; Risk Assessment; Thiophenes; United States

2008
Hepatic effects of duloxetine-II: spontaneous reports and epidemiology of hepatic events.
    Current drug safety, 2008, Volume: 3, Issue:2

    Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Adverse Drug Reaction Reporting Systems; Age Distribution; Aged; Aged, 80 and over; Chemical and Drug Induced Liver Injury; Child; Consumer Product Safety; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Female; Humans; Liver; Liver Diseases; Male; Middle Aged; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Sex Distribution; Thiophenes; Young Adult

2008
Hepatic effects of duloxetine-I: non-clinical and clinical trial data.
    Current drug safety, 2008, Volume: 3, Issue:2

    Topics: Adrenergic Uptake Inhibitors; Alanine Transaminase; Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Bilirubin; Biomarkers; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Consumer Product Safety; Drug Evaluation, Preclinical; Duloxetine Hydrochloride; Humans; Liver; Liver Diseases; Risk Assessment; Risk Factors; Selective Serotonin Reuptake Inhibitors; Species Specificity; Thiophenes

2008

Other Studies

10 other study(ies) available for duloxetine hydrochloride and Chemical and Drug Induced Liver Injury

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
High-content imaging of human hepatic spheroids for researching the mechanism of duloxetine-induced hepatotoxicity.
    Cell death & disease, 2022, 08-01, Volume: 13, Issue:8

    Topics: Chemical and Drug Induced Liver Injury; Depressive Disorder, Major; Duloxetine Hydrochloride; Fatty Liver; Humans

2022
Evaluating Drug-Induced Liver Injury and Its Remission via Discrimination and Imaging of HClO and H
    Analytical chemistry, 2018, 06-19, Volume: 90, Issue:12

    Topics: Antidepressive Agents; Chemical and Drug Induced Liver Injury; Duloxetine Hydrochloride; Fluorescent Dyes; Fluoxetine; Humans; Hydrogen Sulfide; Hypochlorous Acid; Molecular Structure; Optical Imaging; Protons

2018
Dangers of Rapid Dosing: A Case of Dose-Dependent Drug-Induced Liver Injury From Duloxetine.
    The primary care companion for CNS disorders, 2019, Mar-21, Volume: 21, Issue:2

    Topics: Adult; Antidepressive Agents; Chemical and Drug Induced Liver Injury; Diagnosis, Differential; Disease Progression; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Female; Humans; Mental Disorders

2019
Hepatic outcomes among adults taking duloxetine: a retrospective cohort study in a US health care claims database.
    BMC gastroenterology, 2015, Oct-14, Volume: 15

    Topics: Adolescent; Adult; Aged; Chemical and Drug Induced Liver Injury; Databases, Factual; Depression; Drug Utilization Review; Duloxetine Hydrochloride; Female; Humans; Incidence; Insurance, Health; Male; Middle Aged; Propensity Score; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; United States; Venlafaxine Hydrochloride; Young Adult

2015
Hepatic effects of duloxetine-III: analysis of hepatic events using external data sources.
    Current drug safety, 2008, Volume: 3, Issue:2

    Topics: Adrenergic Uptake Inhibitors; Adverse Drug Reaction Reporting Systems; Chemical and Drug Induced Liver Injury; Consumer Product Safety; Cyclohexanols; Databases as Topic; Duloxetine Hydrochloride; Humans; Liver; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Thiophenes; United States; United States Food and Drug Administration; Venlafaxine Hydrochloride

2008
[Mirtazapine-associated hepatotoxicity].
    Medicina clinica, 2010, Nov-06, Volume: 135, Issue:13

    Topics: Antidepressive Agents; Chemical and Drug Induced Liver Injury; Cholestasis; Depressive Disorder; Drug Interactions; Duloxetine Hydrochloride; Humans; Kidney Failure, Chronic; Male; Mianserin; Middle Aged; Mirtazapine; Nephrosclerosis; Thiophenes

2010
Duloxetine hepatotoxicity: a case-series from the drug-induced liver injury network.
    Alimentary pharmacology & therapeutics, 2010, Volume: 32, Issue:9

    Topics: Adult; Antidepressive Agents; Biopsy; Chemical and Drug Induced Liver Injury; Duloxetine Hydrochloride; Female; Humans; Liver; Male; Middle Aged; Prospective Studies; Thiophenes

2010
Duloxetine for depression and the incidence of hepatic events in adults.
    Journal of clinical psychopharmacology, 2011, Volume: 31, Issue:4

    Topics: Adolescent; Adult; Chemical and Drug Induced Liver Injury; Cohort Studies; Depression; Duloxetine Hydrochloride; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Retrospective Studies; Thiophenes; Young Adult

2011
Medical management of depression.
    The New England journal of medicine, 2006, Feb-09, Volume: 354, Issue:6

    Topics: Chemical and Drug Induced Liver Injury; Depressive Disorder; Duloxetine Hydrochloride; Humans; Liver Function Tests; Piperazines; Selective Serotonin Reuptake Inhibitors; Thiophenes; Triazoles

2006